Conference: 4th Annual European Forum for Industrial Biotechnology and The Biobased Economy – EFIB
Published online: Mar 7, 2011
| Event Title | 4th Annual European Forum for Industrial Biotechnology and The Biobased Economy – EFIB |
|---|---|
| Date | Oct 18, 2011 - Oct 20, 2011 |
| Event Details | 4th Annual European Forum for Industrial Biotechnology and The Biobased Economy – EFIB18-20 October 2011 | Amsterdam, The Netherlands EFIB is the market leading conference for the industrial biotechnology sector with the unrivalled line-up of speakers, prevailing exhibition and expanding year to year attendance. 2011 edition will cover topics such as the importance of the CAP for the Bio-based Economy, end users perspectives and market forecast, breakthroughs in industrial biotechnology and biorefinery research, implementing sustainability in sourcing and the value chain, innovative biobased products in the pipeline, sustainable feedstock for a sustainable biobased economy and the importance of the Bio-based Economy in the EU Innovation Policy discussed by the leading experts from the industry, policy-making bodies, NGOs and academia. Presenting companies include L’Oreal, RABO Bank, KLM, Danone, Genencor, Novozymes, DSM, DuPont, Evonik Degussa, Wacker Chemie, EU Commission, Copa-Cogeca and many more! EFIB 2011 will feature pre-conference workshops, 2 plenary and 3 parallel sessions, exhibition and unparallel networking opportunities with over 400 attendees expected. To find out more, log onto the website below. |
| Website | http://www.efibforum.com/ |
| Venue |
Novotel Amsterdam City Hotel Novotel Amsterdam City Hotel Europaboulevard 10 1083 AD Amsterdam The Netherlands H0515@accor.com |
| Contact Details |
Ciaran Little Pira Cleeve Road Leatherhead Surrey KT22 7RU ciaran.little@pira-international.com +44 (0)1372 802063 |
This article has not been tagged with keywords. Be the first to tag this article.
Comment on this article
Please register and login to comment on our features, news and patent summaries.
This article has not been commented on. Be the first to comment on this article.